NTHI Stock Forecast: NeOnc Technologies Holdings, Inc. Price Predictions for 2026-2027
The median 12-month analyst price target for NeOnc Technologies Holdings, Inc. is $18. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 31 of 100 as at 18 Nov 2026 — in the lower half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores NeOnc Technologies Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (67): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Quality (12): Profits are thin or unreliable for the size of the business, or they are not turning into cash.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
NTHI stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on NTHI, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 24 Sept 2026 | Roth Capital | Initiates | Buy | $20 |
| 8 Sept 2026 | BTIG | Reiterates | Buy | $15 |
| 26 May 2026 | BTIG | Reiterates | Buy | $15 |
| 19 May 2026 | Alliance Global Partners | Initiates | Buy | $13 |
| 18 May 2026 | Maxim Group | Initiates | Buy | — |
| 24 Apr 2026 | BTIG | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for NTHI.
This page is one stock. Monday covers all of them.
NTHI appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
NTHI vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 19 Nov 2026, NeOnc Technologies Holdings, Inc. returned −48.0% against +9.2% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
NTHI analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 3123.9×
- Price / book
- —
- EV / EBITDA
- —
Cheaper than 1% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Return on equity
- —
- Return on assets
- −379.6%
- Dividend yield
- —
Higher than 1% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
NeOnc Technologies Holdings, Inc. has a market value of $124.9M and an enterprise value of $114.4M.
Revenue in the twelve months to 30 June 2026: $0.0.
Net income over the same four quarters: −$47.2M.
Free cash flow in the twelve months to 30 June 2026: −$21.7M.
NeOnc Technologies Holdings, Inc. employs 5 people.
Data provided by Twelve Data
NTHI and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at NTHI’s peer groups, ranked by the model: healthcare stocks · biotech stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own NeOnc Technologies Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about NTHI
What is the NTHI stock price forecast for 2026-2027?
The median 12-month analyst price target for NeOnc Technologies Holdings, Inc. is $18, with estimates ranging from $13 to $20. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is NTHI stock a buy right now?
Of the 4 analysts covering NeOnc Technologies Holdings, Inc., 4 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks NeOnc Technologies Holdings, Inc. 31 out of 100 across roughly 4,300 US stocks as at 18 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank NTHI?
As at 18 Nov 2026, NeOnc Technologies Holdings, Inc. ranks 31 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Value (67 of 100).
Will NTHI stock go up?
No one can know that. What the data says: the median 12-month target from 4 analysts is $18, and Ticker Nerd's factor model ranks NeOnc Technologies Holdings, Inc. 31 out of 100 as at 18 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the NTHI stock forecast for 2030?
No analyst covering NeOnc Technologies Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NTHI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $13 to $20 over the next 12 months.
How has NTHI stock performed over the past year?
NeOnc Technologies Holdings, Inc. returned -48.0% over the 12 months to 19 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does NeOnc Technologies Holdings, Inc. do?
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system cancers and other intracranial malignancies. Its current pipeline centers on NEO100, a purified form of perillyl acid being studied in Phase IIa trials, and NEO212, an oral drug candidate evaluated in Phase I/II trials for primary and secondary brain cancers, including glioblastoma, meningioma, and high-grade gliomas.
About NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system cancers and other intracranial malignancies. Its current pipeline centers on NEO100, a purified form of perillyl acid being studied in Phase IIa trials, and NEO212, an oral drug candidate evaluated in Phase I/II trials for primary and secondary brain cancers, including glioblastoma, meningioma, and high-grade gliomas. The company is also developing technologies designed to improve delivery of therapeutics across the blood-brain barrier, a key challenge in treating brain diseases. NeOnc Technologies Holdings, Inc. operates within the biotechnology sector and serves the specialized oncology market with a focus on hard-to-treat brain tumors and related central nervous system conditions.
CEO Mr. Amir Farrokh Heshmatpour · 5 employees · United States · https://www.neonc.com